Edralbrutinib is a selective Bruton’s tyrosine kinase (BTK) inhibitor with a high potency for targeting BTK signaling pathways. This compound demonstrates significant inhibition of B-cell receptor (BCR) signaling, making it a valuable tool for studying diseases such as B-cell malignancies and autoimmune disorders. Research applications include investigation of B-cell signaling dynamics and therapeutic development for BTK-dependent pathologies.
Edralbrutinib is a selective Bruton’s tyrosine kinase (BTK) inhibitor with a high potency for targeting BTK signaling pathways. This compound demonstrates significant inhibition of B-cell receptor (BCR) signaling, making it a valuable tool for studying diseases such as B-cell malignancies and autoimmune disorders. Research applications include investigation of B-cell signaling dynamics and therapeutic development for BTK-dependent pathologies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
